Related Experiment Video
Updated: Feb 11, 2026

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
Published on: December 17, 2019
Obesity induced T cell dysfunction and implications for cancer immunotherapy
Ethan G Aguilar1, William J Murphy2
1Department of Dermatology, UC Davis School of Medicine, Sacramento, CA 95816, USA.
Abstract:
Obesity has been shown to increase risk for a number of different disorders, including cancer. In addition, obesity is also associated with immune dysfunction, which could contribute to its strong association with other comorbidities. Recently, the immune system has been found to be heavily regulated by changes in metabolism. In particular, T cells are able to respond to intrinsic metabolic regulatory mechanisms, as well as extrinsic factors such as the changes in metabolite availability. The dysfunctional metabolic environment created by obesity could therefore have a direct impact on T cell responses. In this review, we highlight recent findings in the fields of T cell biology and obesity, with a focus on mechanisms driving T cell dysfunction and potential implications for immunotherapeutic treatment of cancer.
Related Concept Videos
Obesity
Tumor Immunotherapy
Mechanisms of Retrovirus-induced Cancers
Drug Dosing: Obese Patients
Induced Pluripotent Stem Cells
Cancer Cell Migration through Invadopodia

